Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,021 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Botulinum Toxin: Non-cosmetic Indications and Possible Mechanisms of Action.
Wollina U. Wollina U. J Cutan Aesthet Surg. 2008 Jan;1(1):3-6. doi: 10.4103/0974-2077.41148. J Cutan Aesthet Surg. 2008. PMID: 20300330 Free PMC article.
Lower relapse rate of botulinum toxin A therapy for axillary hyperhidrosis by dose increase.
Karamfilov T, Konrad H, Karte K, Wollina U. Karamfilov T, et al. Among authors: wollina u. Arch Dermatol. 2000 Apr;136(4):487-90. doi: 10.1001/archderm.136.4.487. Arch Dermatol. 2000. PMID: 10768647 Clinical Trial.
A total dose of 200 U of botulinum toxin A was used once per axilla. Patients were observed for up to 15 months. SETTINGS: University medical center. ...
A total dose of 200 U of botulinum toxin A was used once per axilla. Patients were observed for up to 15 months. SETTINGS: University …
Botulinum toxin A for palmar hyperhidrosis.
Wollina U, Karamfilov T. Wollina U, et al. J Eur Acad Dermatol Venereol. 2001 Nov;15(6):555-8. doi: 10.1046/j.1468-3083.2001.00350.x. J Eur Acad Dermatol Venereol. 2001. PMID: 11843216 Clinical Trial.
METHODS: Ten patients with recalcitrant palmar hyperhidrosis were treated with intercutaneous injections of botulinum toxin A (Botox; 200 U for each hand). ...CONCLUSIONS: Botulinum toxin A (200 U Botox per palm) was able to induce long-term remission in palmar hype …
METHODS: Ten patients with recalcitrant palmar hyperhidrosis were treated with intercutaneous injections of botulinum toxin A (Botox; 200 …
High-dose botulinum toxin type A therapy for axillary hyperhidrosis markedly prolongs the relapse-free interval.
Wollina U, Karamfilov T, Konrad H. Wollina U, et al. J Am Acad Dermatol. 2002 Apr;46(4):536-40. doi: 10.1067/mjd.2002.118341. J Am Acad Dermatol. 2002. PMID: 11907503 Clinical Trial.
A total dose of 200 U of BTXA was used per axilla. Patients were followed up for periods up to 29 months. The main outcome measures were patients' satisfaction with the antihidrotic effect, response to repeated treatment, and safety of treatment. ...The number of patients …
A total dose of 200 U of BTXA was used per axilla. Patients were followed up for periods up to 29 months. The main outcome measures w …
Botulinum toxin A in anal fissures: a modified technique.
Wollina U, Konrad H. Wollina U, et al. J Eur Acad Dermatol Venereol. 2002 Sep;16(5):469-71. doi: 10.1046/j.1468-3083.2002.00490.x. J Eur Acad Dermatol Venereol. 2002. PMID: 12428839 Clinical Trial.
Intramuscular injections of 20-25 U BTXA (Botox) were performed in group A (n = 5). In group B (n = 5) those injections were combined with intracutaneous injection of 30-50 U BTXA to treat focal hyperhidrosis. ...
Intramuscular injections of 20-25 U BTXA (Botox) were performed in group A (n = 5). In group B (n = 5) those injections were combined …
Botulinum toxin in dermatology - beyond wrinkles and sweat.
Wollina U, Konrad H, Petersen S. Wollina U, et al. J Cosmet Dermatol. 2005 Dec;4(4):223-7. doi: 10.1111/j.1473-2165.2005.00195.x. J Cosmet Dermatol. 2005. PMID: 17168867
1,021 results
Jump to page
Feedback